SALEM CAPITAL MANAGEMENT INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
SALEM CAPITAL MANAGEMENT INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2022$1,245,000
-11.1%
16,377
-1.2%
0.99%
-3.4%
Q2 2022$1,401,000
-20.1%
16,577
-17.1%
1.02%
+3.8%
Q1 2022$1,754,000
+0.3%
19,9940.0%0.98%
+8.5%
Q4 2021$1,749,000
-30.4%
19,994
-35.0%
0.91%
-34.1%
Q3 2021$2,514,000
+215.0%
30,744
+251.6%
1.38%
+215.1%
Q2 2021$798,000
+10.5%
8,744
+3.6%
0.44%
+1.6%
Q1 2021$722,000
-9.4%
8,4440.0%0.43%
-15.0%
Q4 2020$797,000
+8.6%
8,4440.0%0.51%
-4.7%
Q3 2020$734,000
-0.4%
8,4440.0%0.53%
+0.6%
Q2 2020$737,000
+5.9%
8,4440.0%0.53%
-8.2%
Q1 2020$696,000
-21.4%
8,444
-9.6%
0.58%
+19.5%
Q4 2019$885,000
+9.0%
9,3440.0%0.48%
+3.4%
Q3 2019$812,000
-4.8%
9,3440.0%0.46%
-1.7%
Q2 2019$853,000
-5.0%
9,3440.0%0.47%
-2.7%
Q1 2019$898,000
+5.6%
9,344
-5.6%
0.49%
-9.2%
Q4 2018$850,000
-1.5%
9,903
-1.2%
0.54%
+16.1%
Q3 2018$863,000
+16.8%
10,019
+2.5%
0.46%
+16.4%
Q2 2018$739,000
-11.1%
9,778
-4.9%
0.40%
-12.4%
Q1 2018$831,000
-5.4%
10,280
-1.7%
0.45%
+1.1%
Q4 2017$878,000
-0.6%
10,455
+1.7%
0.45%
-1.8%
Q3 2017$883,000
+2.9%
10,2800.0%0.46%
-5.2%
Q2 2017$858,000
+12.5%
10,2800.0%0.48%
+13.5%
Q1 2017$763,000
-15.7%
10,280
-17.3%
0.42%
-15.1%
Q4 2016$905,000
-23.7%
12,430
-17.2%
0.50%
-23.4%
Q3 2016$1,186,000
-44.7%
15,020
-42.2%
0.65%
-47.4%
Q2 2016$2,145,000
-61.8%
25,994
-66.5%
1.24%
-60.9%
Q1 2016$5,620,000
-14.3%
77,588
+1.8%
3.16%
-14.9%
Q4 2015$6,557,000
-6.4%
76,2130.0%3.71%
-9.8%
Q3 2015$7,005,000
-10.7%
76,213
-4.5%
4.11%
+1.2%
Q2 2015$7,844,000
-0.9%
79,765
-0.6%
4.06%
+1.0%
Q1 2015$7,913,000
+4.6%
80,245
-1.7%
4.02%
+11.7%
Q4 2014$7,567,000
-3.9%
81,665
-2.4%
3.60%
-1.9%
Q3 2014$7,875,000
-3.2%
83,665
-6.9%
3.67%
+1.7%
Q2 2014$8,134,000
+3.7%
89,845
-2.6%
3.61%
+5.0%
Q1 2014$7,843,000
+3.7%
92,250
-1.9%
3.44%
+5.3%
Q4 2013$7,561,000
+4.1%
94,070
-0.6%
3.26%
-2.3%
Q3 2013$7,262,000
+7.2%
94,670
-1.2%
3.34%
+3.4%
Q2 2013$6,774,00095,7953.23%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders